降脂益生菌对动脉样硬化发展的治疗潜力
Mohamed J Saadh1, Behina Bazghandi2, Hamid Jamialahmdi3
1Faculty of Pharmacy, Middle East University, Amman, 11831, Jordan.
European journal of pharmacology
|March 30, 2024
概括
益生菌治疗显示,通过向肠道细菌来管理高胆固醇和动脉样硬化,有望实现. 这些干预措施有助于降低脂质,减少炎症,并对抗有害的细菌代谢物.
科学领域:
- 微生物学与心血管科学 微生物学与心血管科学
- 肠道微生物组研究研究
- 营养生物化学 营养生物化学
背景情况:
- 高胆固醇血症是动脉样硬化的主要危险因素,通常与饮食和生活方式有关.
- 新兴研究强调了胃肠道微生物组在高胆固醇血症和动脉样硬化中的重要作用.
- 肠道微生物组为抗动脉样硬化的新疗法提供了一个可行的目标.
研究的目的:
- 审查肠道微生物组在高胆固醇血症和动脉样硬化中的作用.
- 探索益生菌干预措施在管理这些疾病方面的潜力.
- 概括益生菌的抗原作用,包括降脂和抗炎作用.
主要方法:
- 对调查肠道微生物组和动脉样硬化的研究进行文献综述.
- 对益生菌干预及其对脂质代谢影响的研究分析.
- 对专注于细菌代谢物在动脉生成中的研究进行检查.
主要成果:
- 益生菌在降低脂质水平方面表现出有效性.
- 某些益生菌可以抑制与动脉样硬化相关的炎症过程.
- 益生菌干预可以抑制异位菌代谢产生的细菌代谢产物.
结论:
- 通过益生菌调节肠道微生物组为高胆固醇血症和动脉样硬化提供了一个有希望的治疗途径.
- 益生菌治疗可以有助于脂质管理和减少动脉样硬化炎症.
- 准肠道细菌及其代谢物是预防和治疗动脉样硬化的新方法.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
659
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
659
Inflammation
53.4K
Overview
53.4K
Overview of Lipid Metabolism
1.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.5K
Lipid-derived Compounds in the Human Body
4.4K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.4K
Drugs for Treatment of Constipation-Predominant IBS
162
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
162
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127


